Apolipoprotein E polymorphisms affect atherosclerosis in young males. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group.
- 1 September 1991
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Arteriosclerosis and Thrombosis: A Journal of Vascular Biology
- Vol. 11 (5) , 1237-1244
- https://doi.org/10.1161/01.atv.11.5.1237
Abstract
Investigators in eight communities collected aortas, right coronary arteries, blood and liver samples, and associated information from 720 young males, aged 15-34 years, who died of external causes. Genotypes for apolipoprotein (apo) E isoforms (E2, E3, and E4) were determined from hepatic DNA by restriction isotyping (restriction enzyme isoform genotyping) of amplified apo E sequences. Pathologists graded the arteries for atherosclerotic lesions, and a central laboratory measured lipoprotein cholesterol concentrations. Allele frequencies were different between blacks and whites (p less than 0.0001). E2 and E4 frequencies were higher and E3 frequency was lower in blacks than in whites. Among the common genotypes in both whites and blacks, E2E3 heterozygotes had the lowest levels of total serum cholesterol and low density lipoproteins, E3E4 had the highest levels, and E3E3 had intermediate levels. Apo E genotypes differed in mean percent surface area involvement with lesions in the thoracic aorta and the abdominal aorta of both whites and blacks (p less than or equal to 0.0002). Among the common genotypes, E2E3 heterozygotes had the least involvement of both thoracic and abdominal aortas with lesions, E3E4 had the greatest involvement (with the exception of the thoracic aorta in whites), and E3E3 had intermediate involvement. Apo E genotype accounted for 5.7% in whites and 5.9% in blacks of the observed variation in lesions for the thoracic aorta, and for 5.9% in whites and 7.0% in blacks for the abdominal aorta. Adjusting for cholesterol levels did not change apo E genotypic effects appreciably, an observation suggesting that genotypic effects on arterial lesions may not be mediated entirely by changes in serum cholesterol concentrations.Keywords
This publication has 14 references indexed in Scilit:
- Differential distribution of apolipoprotein E isoforms in human plasma lipoproteins.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- Apoprotein E polymorphism and coronary artery disease. Increased prevalence of apolipoprotein E-4 in angiographically verified coronary patients.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- A simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Research, 1988
- Apolipoprotein E polymorphism and atherosclerosis.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1988
- The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individualsAmerican Journal of Medical Genetics, 1987
- A Receptor-Mediated Pathway for Cholesterol HomeostasisScience, 1986
- Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell AnemiaScience, 1985
- Polymorphism at the Apoprotein‐E locus in relation to risk of coronary diseaseClinical Genetics, 1984
- Unresolved problems in the diet-heart issue.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1981
- Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modificationBiochemistry, 1981